Smoking Cessation Aids Market Size

Smoking Cessation Aids Market Analysis

The smoking cessation aid market is expected to register a CAGR of 12.5% over the forecast period.

COVID-19 significantly impacted market growth. The reduced social interaction and increased social isolation led to increased daily stress for many, increasing cigarette smoking cases. For instance, according to an article published in Nature Public Health Emergency Collection in November 2022, it was observed that the sales of cigarettes increased during the pandemic period as compared to the pre-pandemic period. Smoking prevalence was higher among people with HIV than the general population. However, the increased cases of COVID-19 hospitalization increased the demand for nicotine products as it can inhibit the penetration and spread of coronavirus with a prophylactic effect on COVID-19 infection. For instance, as per an article published by the UW-Center for Tobacco Research and Intervention (CTRI) in August 2022, it was observed that prescriptions for nicotine gum, tablets, or patches were associated with reduced mortality among smokers hospitalized with COVID-19. Moreover, with the increased use of smoking cessation devices, such as e-cigarettes, nicotine products, and others, among the population, the studied market witnessed significant growth. It is expected to grow over the forecast period.

Factors such as the large population addicted to smoking, awareness of the hazards of smoking, and banning advertisements of tobacco products are expected to boost market growth over the forecast period.

The increasing government and organization initiatives in organizing various tobacco and smoking cessation campaigns increase awareness among the population regarding their harmful effects on the body. It is anticipated to increase the adoption of smoking cessation devices and products among users, propelling market growth. For instance, in May 2022, the Karnataka health minister, K Sudhakar, India, launched the IndiaVsTobacco campaign, including QR code-enabled billboards and posters. It engaged young people, parents, and institutions to work towards a tobacco-free country. The interactive billboards seek to start discussions on the hazards of secondhand smoke and the health risks tobacco use poses to the community. Also, in May 2021, the World Health Organization (WHO) China Office and the Planning and Information Department of the National Health Commission (NHC) launched China's WNTD 2021 campaign and China Cessation Platform mini program.

Additionally, the increasing use of tobacco in the form of cigarettes increased globally over time, creating a healthcare burden. For instance, as per the data published by the WHO data in May 2022, it was observed that 22.3% of the global population used tobacco during the pandemic period, of which men accounted for 36.7% of the total world's male population, and women accounted for 7.8% of the world's women population. Therefore, with the increasing number of smokers worldwide, the usage of nicotine replacement therapy and smoking cessation products is increasing, which is expected to fuel the market growth over the forecast period.

Furthermore, the rising company focus on developing and launching smoking cessation drugs and devices in the market is expected to increase their adoption among users, which is anticipated to augment the market growth over the forecast period. For instance, in February 2022, betapharm Arzneimittel GmbH launched the first generic nicotine chewing gum, Nicotine Beta, in the German market. It offers a generic product underlining the advantages of NRT (Nicotine Replacement Therapy).

Therefore, the studied market is expected to grow over the forecast period due to the factors above. However, the adverse effects of drugs are likely to impede the market's growth over the forecast period.